tiprankstipranks
Kamada’s Strong Growth and Strategic Expansion in 2024
Company Announcements

Kamada’s Strong Growth and Strategic Expansion in 2024

Kamada (KMDA) has released an update.

Don't Miss our Black Friday Offers:

Kamada Ltd. reported a robust financial performance for the third quarter and first nine months of 2024, with a 15% year-over-year increase in revenues up to $121.9 million and a 43% rise in adjusted EBITDA to $25.4 million. The company has raised its annual adjusted EBITDA guidance and maintained its revenue forecast, reflecting strong demand for its products and strategic expansion efforts, including a new plasma collection center in Houston. Kamada’s solid operational cash flow and cash reserves further highlight its potential for sustained growth in the specialty plasma-derived sector.

For further insights into KMDA stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyKamada reports Q3 EPS 7c, consensus 7c
TheFlyKamada sees FY24 revenue $158M-$162M, consensus $160.47M
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App